Israel Corp. Reports Results for Third Quarter of 2025
Israel Corporation (TASE: ILCO) reported third quarter results for the period ended September 30, 2025. Key items: ILCO share in ICL profit $51m, Prodalim profit $1m, amortization and HQ costs of <$3m> each, and net profit to shareholders $46m.
Liquidity: ILCO reported financial liabilities $660m and investments in liquid assets $695m (including $8m pledged), leaving a $35m liquid-asset surplus and net cash $45m as of Sept 30, 2025 (up from $26m on June 30, 2025); this net cash reflects a $10m derivatives adjustment reducing economic liabilities.
Balance sheet: total assets include ICL market value $3,550m, Prodalim cost $118m, AKVA market value $62m, other $19m, giving total assets $3,749m and total assets, net $3,794m.
Israel Corporation (TASE: ILCO) ha riportato i risultati del terzo trimestre per il periodo terminato il 30 settembre 2025. Elementi chiave: quota di ILCO sul profitto ICL 51 mln $, Profitto di Prodalim 1 mln $, ammortamenti e costi della sede di <$3m> ciascuno, e utile netto agli azionisti 46 mln $.
Liquidità: ILCO ha riportato passività finanziarie $660m e investimenti in attività liquide $695m (di cui $8m impegnati), lasciando un avanzo di liquidità di $35m e cassa netta $45m al 30 settembre 2025 (rispetto ai $26m del 30 giugno 2025); questa cassa netta riflette una regolazione derivati di $10m che riduce le passività economiche.
Stato patrimoniale: attività totali includono valore di mercato ICL $3.550m, costo Prodalim $118m, valore di mercato AKVA $62m, altri $19m, per un totale attività $3.749m e attività totali nette $3.794m.
Israel Corporation (TASE: ILCO) informó resultados del tercer trimestre para el periodo terminado al 30 de septiembre de 2025. Elementos clave: participación de ILCO en la ganancia de ICL $51m, ganancia de Prodalim $1m, amortización y costos de la sede de <$3m> cada uno, y beneficio neto para los accionistas $46m.
Liquidez: ILCO reportó pasivos financieros $660m y inversiones en activos líquidos $695m (incluyendo $8m comprometidos), dejando un excedente de liquidez de $35m y efectivo neto $45m al 30 de septiembre de 2025 (frente a $26m al 30 de junio de 2025); este efectivo neto refleja un ajuste de derivados de $10m que reduce las liabilities económicas.
Balance general: activos totales incluyen valor de mercado ICL $3,550m, costo de Prodalim $118m, valor de mercado AKVA $62m, otros $19m, dando activos totales $3,749m y activos totales netos $3,794m.
Israel Corporation (TASE: ILCO)은 2025년 9월 30일 종료된 기간에 대한 3분기 실적을 보고했습니다. 주요 항목: ICL 이익에서의 ILCO 지분 $5100만, 프로달림 이익 $100만, 각 <$3m>의 상각 및 본사 비용, 그리고 주주에게 돌아간 순이익 $4600만입니다.
유동성: ILCO는 재무부채 $660m와 유동자산 투자 $695m를 보고했으며(약속된 $8m 포함), 9월 30일 2025년 기준으로 $35m의 유동성 흑자와 순현금 $45m를 남겼고(2025년 6월 30일의 $26m에서 증가); 이 순현금은 경제적 부채를 감소시키는 파생상품 조정 $10m를 반영합니다.
대차대조표: 총자산에는 ICL 시가 $3,550m, Prodalim 원가 $118m, AKVA 시가 $62m, 기타 $19m이 포함되어 총자산 $3,749m와 순자산 $3,794m입니다.
Israel Corporation (TASE: ILCO) a publié les résultats du troisième trimestre pour la période se terminant le 30 septembre 2025. Points clés : participation d'ILCO dans le bénéfice d'ICL 51 M$, bénéfice de Prodalim 1 M$, amortissements et coûts du siège de < $3m > chacun, et bénéfice net pour les actionnaires 46 M$.
Liquidité : ILCO a déclaré des passifs financiers 660 M$ et des investissements en actifs liquides 695 M$ (dont 8 M$ engagés), laissant un excédent de liquidité de 35 M$ et caisse nette 45 M$ au 30 septembre 2025 (contre 26 M$ au 30 juin 2025); cette caisse nette reflète un ajustement de dérivés de 10 M$ réduisant les passifs économiques.
Bilan : les actifs totaux incluent valeur de marché ICL 3 550 M$, coût Prodalim 118 M$, valeur de marché AKVA 62 M$, autres 19 M$, soit actifs totaux 3 749 M$ et actifs totaux nets 3 794 M$.
Israel Corporation (TASE: ILCO) berichtete die Ergebnisse des dritten Quartals für den Zeitraum zum 30. September 2025. Wichtige Punkte: ILCO-Anteil am ICL-Gewinn 51 Mio. $, Prodalim-Gewinn 1 Mio. $, Abschreibungen und HQ-Kosten von <$3m> jeweils, und Nettoergebnis für Aktionäre 46 Mio. $.
Liquidität: ILCO meldete finanzielle Verbindlichkeiten $660m und Investitionen in liquide Mittel $695m (einschließlich $8m pledged), was am 30. September 2025 einen Liquiditätsüberschuss von $35m und Netto-Cash $45m ergibt (gegenüber $26m am 30. Juni 2025); dieses Netto-Cash spiegelt eine Derivate-Anpassung von $10m wider, die die wirtschaftlichen Verbindlichkeiten reduziert.
Bilanz: Gesamtvermögen umfasst Marktwert ICL $3.550m, Prodalim-Kosten $118m, AKVA-Markwert $62m, Sonstiges $19m, was zu Gesamtvermögen $3.749m und Nettovermögen $3.794m führt.
Israel Corporation (TASE: ILCO) أبلغت عن نتائج الربع الثالث للفترة المنتهية في 30 سبتمبر 2025. العناصر الأساسية: حصة ILCO في ربح ICL 51 مليون دولار، ربح Prodalim 1 مليون دولار، الاستهلاك وتكاليف المقر بقدره <$3m> لكل منهما، وصافي الربح للمساهمين 46 مليون دولار.
السيولة: أبلغت ILCO عن الالتزامات المالية 660 مليون دولار واستثمارات في أصول سائلة 695 مليون دولار (بما في ذلك 8 ملايين دولار مطلوب رهنها)، مما يترك فائض سيولة قدره 35 مليون دولار وصافي النقد 45 مليون دولار حتى 30 سبتمبر 2025 (ارتفاع من 26 مليون دولار في 30 يونيو 2025)؛ يعكس هذا النقد الصافي تعديل مشتقات بقيمة 10 ملايين دولار يقلل الالتزامات الاقتصادية.
الميزانية: تشمل الأصول الإجمالية قيمة سوق ICL 3,550 مليون دولار، تكلفة Prodalim 118 مليون دولار، قيمة AKVA السوقية 62 مليون دولار، آخرون 19 مليون دولار، مما يعطي إجمالي الأصول 3,749 مليون دولار والأصول الإجمالية الصافية 3,794 مليون دولار.
- Net cash increased to $45m from $26m (Jun 30, 2025)
- ICL market value of $3,550m represents roughly 95% of ILCO's reported assets
- Total financial liabilities remain substantial at $660m despite liquid assets of $695m
Selected Financial Figures for the Third Quarter 2025:
|
$m |
Q 3 /2 5 |
Q 3 / 24 |
|
ILCO share in ICL profit |
51 |
50 |
|
ILCO share in Prodalim profit |
1 |
- |
|
Amortization of excess cost in held companies |
(3) |
(1) |
|
Financing, G&A and other at ILCO headquarter level |
(3) |
(1) |
|
Net profit to company's shareholders |
46 |
49 |
|
|
|
|
Liquidity at the ILCO Headquarters Level[1]
As of September 30, 2025, total financial liabilities were
Net cash[1] as of September 30, 2025, totaled
ILCO Total Assets, Net
|
$m |
30/09/2025 |
|
Assets |
|
|
ICL (~567m shares, market value) |
3,550 |
|
Prodalim (cost) |
118 |
|
AKVA Group (~6.6m shares, market value) |
62 |
|
Other (market value)[2] |
19 |
|
Total Assets |
3,749 |
|
ILCO's Net Cash |
45 |
|
Total Assets, net |
3,794 |
About Israel Corporation
For further information on ILCO, see ILCO's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il.
Please also see ILCO company website http://www.israelcorp.com for additional information.
Convenience Translation
The financial information found in this press release is an English summary based on the original Hebrew financial statements and is solely for the convenience of the reader. The binding version is the original in Hebrew.
Forward Looking Statements
This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of ILCO, which may cause actual results to differ materially from those contained in the disclosures.
Investor Relations Contacts
Idan Hizki
Vice President, Business Development
Tel: +972 3 684 4500
idanh@israelcorp.com
[1] Israel Corp and its wholly owned and controlled headquarter companies.
[2] Includes 1.983m shares in Nordic Aqua Partners (OB:NOAP).
View original content:https://www.prnewswire.com/news-releases/israel-corp-reports-results-for-third-quarter-of-2025-302620642.html
SOURCE Israel Corporation Ltd.
FAQ
What did Israel Corporation (TASE: ILCO) report for net cash on Sept 30, 2025?
How large is ILCO's holding in ICL according to the Q3 2025 report?
What were Israel Corporation's total financial liabilities and liquid assets on Sept 30, 2025?
What was ILCO's net profit to shareholders for Q3 2025?
How does the derivatives adjustment affect ILCO's net cash on Sept 30, 2025?
